Home

Mercury Laboratories Ltd EPS

Image

Mercury Laboratories Ltd

NSE: MERCURYLABS

EPS

₹ 32.88

Last updated on: Feb 21, 2025

Key Highlights

  • The Earning per Share of Mercury Laboratories Ltd is ₹ 32.88 as of 21 Feb 25 .
  • The earning per share of Mercury Laboratories Ltd changed from ₹ 8.33 to ₹ 9.94 over 7 quarters. This represents a CAGR of 10.62% .

Historical Earning per Share of Mercury Laboratories Ltd

No data available

* All values are in

Company Fundamentals for Mercury Laboratories Ltd

Market Cap

102 Cr

EPS

32.9

P/E Ratio (TTM)

26.1

P/B Ratio (TTM)

2.0

Day’s High

890.0

Day’s Low

825.0

DTE

0.1

ROE

7.7

52 Week High

1190.0

52 Week Low

760.0

ROCE

10.5

Market Price of Mercury Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Mercury Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 2025857.7
20 Feb 2025860
19 Feb 2025829.8
18 Feb 2025809.15
17 Feb 2025819.5
14 Feb 2025849
13 Feb 2025818.1
12 Feb 2025851
11 Feb 2025829
10 Feb 2025837.45

SWOT Analysis Of Mercury Laboratories Ltd

Strength

1

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Mercury Laboratories Ltd

Asset Value vs Market Value of Mercury Laboratories Ltd

Market Value

103

Asset Value

Value addition

1.5 X

41

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Mercury Laboratories Ltd102.92
Sun Pharmaceuticals Industries Ltd394223
Divis Laboratories Ltd152610
Cipla Ltd119067
Torrent Pharmaceuticals Ltd102739
Dr Reddys Laboratories Ltd96124

Historical Market Cap of Mercury Laboratories Ltd

No data available

* All values are in crore

Historical Revenue of Mercury Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Mercury Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Mercury Laboratories Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Mercury Laboratories Ltd News Hub

Mercury Laboratories schedules board meeting

Mercury Laboratories will hold a meeting of the Board of Directors of the Company on 14 November 202

Read more

07 Nov 24

Mercury Laboratories to table results

Mercury Laboratories will hold a meeting of the Board of Directors of the Company on 12 February 202

Read more

07 Feb 25

Mercury Laboratories standalone net profit declines 66.89% in the September 2024 quarter

Net profit of Mercury Laboratories declined 66.89% to Rs 0.50 crore in the quarter ended September 2

Read more

15 Nov 24

Mercury Laboratories standalone net profit declines 4.03% in the December 2024 quarter

Net profit of Mercury Laboratories declined 4.03% to Rs 1.19 crore in the quarter ended December 202

Read more

13 Feb 25

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Mercury Laboratories Ltd

What is the EPS of Mercury Laboratories Ltd stock?

The Earnings Per Share (EPS) of Mercury Laboratories Ltd is 32.88. An EPS is the amount of net income attributed to each share of a common stock.

How is Mercury Laboratories Ltd EPS calculated?

The EPS of Mercury Laboratories Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Mercury Laboratories Ltd report its EPS?

Mercury Laboratories Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Mercury Laboratories Ltd EPS?

Factors that influence the EPS of Mercury Laboratories Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Mercury Laboratories Ltd EPS growth indicate future performance?

Yes, consistent growth in Mercury Laboratories Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions